APA
Buzdar A. U., Hortobagyi G. N., Frye D., Ho D., Booser D. J., Valero V., Holmes F. A., Birmingham B. K., Bui K. & Yeh C. (19940131). Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Buzdar A U, Hortobagyi G N, Frye D, Ho D, Booser D J, Valero V, Holmes F A, Birmingham B K, Bui K and Yeh C. 19940131. Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Buzdar A. U., Hortobagyi G. N., Frye D., Ho D., Booser D. J., Valero V., Holmes F. A., Birmingham B. K., Bui K. and Yeh C. (19940131). Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Buzdar A U, Hortobagyi G N, Frye D, Ho D, Booser D J, Valero V, Holmes F A, Birmingham B K, Bui K and Yeh C. Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19940131.